ANGLE plc announced the appointment of Dr. Jan Groen as a Non-Executive Director of the company effective 1 November 2018. Dr. Groen has extensive Board and Executive level experience in cancer diagnostics. He is currently President and CEO of MDxHealth, a Euronext listed molecular diagnostic company that develops and commercialises cancer diagnostic tests to assist physicians in the detection and treatment of urological and other cancers, a position he has held since 2010. Prior to MDx Health, Dr. Groen was President of US Operations and Global Chief Operating Officer at Agendia, a world leader in the rapidly evolving field of cancer molecular diagnostics using tumor gene expression, including tests that predict the risk of breast cancer recurrence (MammaPrint) and to identify the origin of cancer of unknown primary.